Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours
Status:
Completed
Trial end date:
2018-07-09
Target enrollment:
Participant gender:
Summary
This is a phase Ib, open-label, multicentre study of AZD1775 administered orally in
monotherapy and in combination with carboplatin and paclitaxel to Asian patients with
advanced solid tumours.